IP Verse

Improved Lipid Nanoparticles For Delivery Of Nucleic Acids

Patent No. EP4013385 (titled "Improved Lipid Nanoparticles For Delivery Of Nucleic Acids") was filed by Acuitas Therapeutics on Aug 14, 2020. The application was issued on Jul 3, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABEL & IMRAYApr 3, 2025ABEL & IMRAY
ARNASON FAKTORApr 3, 2025ARNASON FAKTOR
MARGARET DIXONApr 3, 2025MEWBURN ELLIS
STRAWMANApr 2, 2025HOFFMANN EITLE
GRAF VON STOSCHApr 1, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
JAMES POOLENov 28, 2024CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4013385

ACUITAS THERAPEUTICS
Application Number
EP20765121A
Filing Date
Aug 14, 2020
Status
Granted And Under Opposition
May 31, 2024
Publication Date
Jul 3, 2024
External Links
Slate, Register , Google Patents